BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
114 hedge funds and large institutions have $259M invested in BioSpecifics Technologies Corp. in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 16 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
2% less capital invested
Capital invested by funds: $264M → $259M (-$5.37M)
3% less funds holding
Funds holding: 117 → 114 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$4.49M |
| 2 |
Millennium Management
New York
|
+$4.11M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$3.28M |
| 4 |
RC
Roubaix Capital
Denver,
Colorado
|
+$2.84M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$2.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$9.02M |
| 2 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$4.61M |
| 3 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$4.59M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.42M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.1M |
BSTC Hedge Fund Activity: Q2 2019 in Review
114 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2019, worth a combined $259M — down 2% from $264M a quarter earlier.
Fund positioning in BSTC was balanced in Q2 2019: 16 funds opened new positions, 16 closed out, 51 added to existing stakes and 34 trimmed.
The largest buyer was Nuveen, opening a new position worth an estimated $4.49M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $9.02M sold.
- 114 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2019, down from 117 in Q1 2019.
- Funds reported $259M of BioSpecifics Technologies Corp. stock for Q2 2019, down 2% quarter-over-quarter.
- 16 funds opened new BioSpecifics Technologies Corp. positions in Q2 2019 and 16 closed out, a net change of 0 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q2 2019 was Nuveen, an estimated $4.49M added.
- The largest BioSpecifics Technologies Corp. seller in Q2 2019 was Acadian Asset Management, an estimated $9.02M sold.
Based on aggregated 13F filings for Q2 2019.